Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43


Flow Cytometry: To Dump or Not To Dump.

Boesch M, Cosma A, Sopper S.

J Immunol. 2018 Oct 1;201(7):1813-1815. doi: 10.4049/jimmunol.1801037. No abstract available.


Evaluation of Vav3.1 as prognostic marker in endometrial cancer.

Boesch M, Sopper S, Marth C, Fiegl H, Wiedemair A, Rössler J, Hatina J, Wolf D, Reimer D, Zeimet AG.

J Cancer Res Clin Oncol. 2018 Oct;144(10):2067-2076. doi: 10.1007/s00432-018-2725-2. Epub 2018 Aug 6.


Management of adverse events related to checkpoint inhibition therapy.

Rudzki JD.

Memo. 2018;11(2):132-137. doi: 10.1007/s12254-018-0416-y. Epub 2018 Jun 12. Review.


CD8+HLADR+ Regulatory T Cells Change With Aging: They Increase in Number, but Lose Checkpoint Inhibitory Molecules and Suppressive Function.

Lukas Yani S, Keller M, Melzer FL, Weinberger B, Pangrazzi L, Sopper S, Trieb K, Lobina M, Orrù V, Fiorillo E, Cucca F, Grubeck-Loebenstein B.

Front Immunol. 2018 Jun 4;9:1201. doi: 10.3389/fimmu.2018.01201. eCollection 2018.


Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.

Wanner D, Bohn JP, Rudzki J, Stockhammer G, Steurer M.

Ann Hematol. 2018 May 26. doi: 10.1007/s00277-018-3381-y. [Epub ahead of print] No abstract available.


(Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer.

Boesch M, Reimer D, Sopper S, Wolf D, Zeimet AG.

Oncologist. 2018 Jul;23(7):757-759. doi: 10.1634/theoncologist.2017-0683. Epub 2018 Apr 19. No abstract available.


Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.

Klepsch V, Hermann-Kleiter N, Do-Dinh P, Jakic B, Offermann A, Efremova M, Sopper S, Rieder D, Krogsdam A, Gamerith G, Perner S, Tzankov A, Trajanoski Z, Wolf D, Baier G.

Nat Commun. 2018 Apr 18;9(1):1538. doi: 10.1038/s41467-018-04004-2.


Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness.

Boesch M, Onder L, Cheng HW, Novkovic M, Mörbe U, Sopper S, Gastl G, Jochum W, Ruhstaller T, Knauer M, Ludewig B.

Oncoimmunology. 2018 Jan 3;7(4):e1414129. doi: 10.1080/2162402X.2017.1414129. eCollection 2018.


Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling.

Remm F, Kränkel N, Lener D, Drucker DJ, Sopper S, Brenner C.

Stem Cells Int. 2018 Feb 8;2018:5284963. doi: 10.1155/2018/5284963. eCollection 2018.


Correction for Wu et al., "Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling".

Wu A, Tymoszuk P, Haschka D, Heeke S, Dichtl S, Petzer V, Seifert M, Hilbe R, Sopper S, Talasz H, Bumann D, Lass-Flörl C, Theurl I, Zhang K, Weiss G.

Infect Immun. 2018 Feb 20;86(3). pii: e00881-17. doi: 10.1128/IAI.00881-17. Print 2018 Mar. No abstract available.


Immunophenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfaces.

Cappellano G, Ploner C, Lobenwein S, Sopper S, Hoertnagl P, Mayerl C, Wick N, Pierer G, Wick G, Wolfram D.

PLoS One. 2018 Feb 8;13(2):e0192108. doi: 10.1371/journal.pone.0192108. eCollection 2018.


Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.

Reimer D, Boesch M, Wolf D, Marth C, Sopper S, Hatina J, Altevogt P, Parson W, Hackl H, Zeimet AG.

Int J Cancer. 2018 Apr 15;142(8):1640-1651. doi: 10.1002/ijc.31186. Epub 2017 Dec 14.


Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies.

Crazzolara R, Kropshofer G, Steurer M, Sopper S, Schwinger W.

J Vis Exp. 2017 Sep 6;(127). doi: 10.3791/56002.


Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.

Sauermann U, Radaelli A, Stolte-Leeb N, Raue K, Bissa M, Zanotto C, Krawczak M, Tenbusch M, Überla K, Keele BF, De Giuli Morghen C, Sopper S, Stahl-Hennig C.

J Virol. 2017 Sep 13. pii: JVI.01120-17. doi: 10.1128/JVI.01120-17. [Epub ahead of print]


Salmonella utilizes zinc to subvert anti-microbial host defense of macrophages via modulation of NF-κB signaling.

Wu A, Tymoszuk P, Haschka D, Heeke S, Dichtl S, Petzer V, Seifert M, Hilbe R, Sopper S, Talasz H, Bumann D, Lass-Flörl C, Theurl I, Zhang K, Weiss G.

Infect Immun. 2017 Sep 5. pii: IAI.00418-17. doi: 10.1128/IAI.00418-17. [Epub ahead of print] Erratum in: Infect Immun. 2018 Feb 20;86(3):.


The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3+CD8+ tumor infiltrating lymphocyte subpopulations.

Koeck S, Kern J, Zwierzina M, Gamerith G, Lorenz E, Sopper S, Zwierzina H, Amann A.

Oncoimmunology. 2017 May 8;6(6):e1323617. doi: 10.1080/2162402X.2017.1323617. eCollection 2017.


HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation.

Clausen J, Böhm A, Straßl I, Stiefel O, Buxhofer-Ausch V, Machherndl-Spandl S, König J, Schmidt S, Steitzer H, Danzer M, Kasparu H, Weltermann A, Nachbaur D.

Biomedicines. 2017 Mar 28;5(2). pii: E13. doi: 10.3390/biomedicines5020013.


Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.

Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, Ferrant A, Gedde-Dahl T, Hellmann A, Janssen J, Labar B, Lang A, Majeed W, Mihaylov G, Stentoft J, Stenke L, Thaler J, Thielen N, Verhoef G, Voglova J, Ossenkoppele G, Hochhaus A, Hjorth-Hansen H, Mustjoki S, Sopper S, Giles F, Porkka K, Wolf D, Gjertsen BT.

Haematologica. 2017 Aug;102(8):1361-1367. doi: 10.3324/haematol.2017.167080. Epub 2017 May 18.


Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples.

Boesch M, Hoflehner E, Wolf D, Gastl G, Sopper S.

J Vis Exp. 2017 May 10;(123). doi: 10.3791/55634.


Short overview on the current treatment of chronic myeloid leukemia in chronic phase.

Schmidt S.

Memo. 2016;9(4):157-162. doi: 10.1007/s12254-016-0299-8. Epub 2016 Dec 14. Review.

Supplemental Content

Loading ...
Support Center